Characterization of celecoxib and valdecoxib binding to cyclooxygenase

被引:55
作者
Hood, WF [1 ]
Gierse, JK [1 ]
Isakson, PC [1 ]
Kiefer, JR [1 ]
Kurumbail, RG [1 ]
Seibert, K [1 ]
Monahan, JB [1 ]
机构
[1] Pharmacia Res & Dev, St Louis, MO USA
关键词
D O I
10.1124/mol.63.4.870
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Two compounds (celecoxib and valdecoxib) from the diarylheterocycle class of cyclooxygenase inhibitors were radiolabeled and used to characterize their binding to cyclooxygenase-1 (COX-1), cyclooxygenase-2 (COX-2), several single-point variants of COX-2 (Val523Ile, Tyr355Ala, Arg120Ala, Arg120Gln, Arg120Asn) and one triple-point variant of COX-2 [Val523Ile, Arg513His, Val434Ile (IHI)]. We demonstrate highly specific and saturable binding of these inhibitors to COX-2. Under the same assay conditions, little or no specific binding to COX-1 could be detected. The affinity of [H-3]celecoxib for COX-2 (K-D = 2.3 nM) was similar to the affinity of [H-3]valdecoxib (K-D = 3.2 nM). The binding to COX-2 seems to be both rapid and slowly reversible with association rates of 5.8 x 10(6)/M/min and 4.5 x 10(6)/M/min and dissociation rates of 14 X 10(-3)/min (t(1/2) = 50 min) and 7.0 X 10(-3)/min (t(1/2) = 98 min) for [H-3]celecoxib and [H-3]valdecoxib, respectively. These association rates increased (4- to 11-fold) when the charged arginine residue located at the entrance to the main hydrophobic channel was mutated to smaller uncharged amino acids (Arg120Ala, Arg120Gln, and Arg120Asn). Mutation of residues located within the active site of COX-2 that define a 'side pocket' (Tyr355Ala, Val523IOle, IHI) of the main channel had a greater effect on the dissociation rate than the association rate. These mutations, which modified the shape of and access to the 'side pocket', affected the binding affinity of [H-3]valdecoxib more than that of [H-3]celecoxib. These binding studies provide direct insight into the properties and binding constants of celecoxib and valdecoxib to COX-2.
引用
收藏
页码:870 / 877
页数:8
相关论文
共 35 条
[1]   PURIFICATION, CHARACTERIZATION AND SELECTIVE-INHIBITION OF HUMAN PROSTAGLANDIN-G/H SYNTHASE-1 AND SYNTHASE-2 EXPRESSED IN THE BACULOVIRUS SYSTEM [J].
BARNETT, J ;
CHOW, J ;
IVES, D ;
CHIOU, M ;
MACKENZIE, R ;
OSEN, E ;
NGUYEN, B ;
TSING, S ;
BACH, C ;
FREIRE, J ;
CHAN, H ;
SIGAL, E ;
RAMESHA, C .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1994, 1209 (01) :130-139
[2]   Involvement of arginine 120, glutamate 524, and tyrosine 355 in the binding of arachidonate and 2-phenylpropionic acid inhibitors to the cyclooxygenase active site of ovine prostaglandin endoperoxide H synthase-1 [J].
Bhattacharyya, DK ;
Lecomte, M ;
Rieke, CJ ;
Garavito, RM ;
Smith, WL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (04) :2179-2184
[3]   Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. [J].
Bombardier, C ;
Laine, L ;
Reicin, A ;
Shapiro, D ;
Burgos-Vargas, R ;
Davis, B ;
Day, R ;
Ferraz, MB ;
Hawkey, CJ ;
Hochberg, MC ;
Kvien, TK ;
Schnitzer, TJ ;
Weaver, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) :1520-1528
[4]  
Callan OH, 1996, J BIOL CHEM, V271, P3548
[5]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[6]   A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitors [J].
Gierse, JK ;
McDonald, JJ ;
Hauser, SD ;
Rangwala, SH ;
Koboldt, CM ;
Seibert, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (26) :15810-15814
[7]   Kinetic basis for selective inhibition of cyclo-oxygenases [J].
Gierse, JK ;
Koboldt, CM ;
Walker, MC ;
Seibert, K ;
Isakson, PC .
BIOCHEMICAL JOURNAL, 1999, 339 :607-614
[8]   EXPRESSION AND SELECTIVE-INHIBITION OF THE CONSTITUTIVE AND INDUCIBLE FORMS OF HUMAN CYCLOOXYGENASE [J].
GIERSE, JK ;
HAUSER, SD ;
CREELY, DP ;
KOBOLDT, C ;
RANGWALA, SH ;
ISAKSON, PC ;
SEIBERT, K .
BIOCHEMICAL JOURNAL, 1995, 305 :479-484
[9]   The interaction of arginine 106 of human prostaglandin G/H synthase-2 with inhibitors is not a universal component of inhibition mediated by nonsteroidal anti-inflammatory drugs [J].
Greig, GM ;
Francis, DA ;
Falgueyret, JP ;
Ouellet, M ;
Percival, MD ;
Roy, P ;
Bayly, C ;
Mancini, JA ;
ONeill, GP .
MOLECULAR PHARMACOLOGY, 1997, 52 (05) :829-838
[10]   Role of Val(509) in time-dependent inhibition of human prostaglandin H synthase-2 cyclooxygenase activity by isoform-selective agents [J].
Guo, QP ;
Wang, LH ;
Ruan, KH ;
Kulmacz, RJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (32) :19134-19139